Commonwealth Biotechnologies, Inc. and Venturepharm Laboratories Ltd have formed a China-based joint venture that will provide a continuous spectrum of outsourcing services. The move came after Venturepharm bought a 39% stake in CBI. The 2.15 million block of shares, which had previously belonged to PharmAust Ltd., has a market value of $5.85 million. More details...

Stock Symbols: (NSDQCM: CBTE) (HKEX: 8225)